Drugs / DMUC4064A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02146313 | Jun 2014 → Jun 2018 | ovarian cancer, pancreatic neoplasm | Genentech, Inc. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DMUC4064A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02146313 ↗ |
| Known as | RG-7882 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297937 ↗ |
| Known as | Thiomab | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297937 ↗ |
| Route | Intravenous | “administered intravenously” NCT02146313 ↗ |